Algenis logo

Algenis

Pioneering the future of muscle relaxation and neurological health through innovative marine microalgae bioactives.

est. 2002

VS
Flare Therapeutics logo

Flare Therapeutics

Trailblazing the path to drugging transcription factors to discover precision medicines for cancer & other disease areas

62 employees · est. 2021 · Cambridge, United States

Algenis is the older company (2002 vs 2021).

Side-by-Side Comparison

Algenis Flare Therapeutics
Founded
2002 older 2021
Headquarters
Not tracked yet Cambridge, United States
Employees
Not tracked yet 62
Industry
Biotechnology, Pharmaceutical Biopharma, Biotechnology, Health Care
Funding Stage
Series Unknown Series B
Total Funding
Not tracked yet $205.00M
Funding Rounds
4 2
Services
Not tracked yet Development of small molecules for cancer treatment, Research and innovation in transcriptional control
Target Customers
Not tracked yet Medical professionals, Oncology researchers, Healthcare institutions, Patients with cancer
Taxonomy
Marine Microalgae, Bioactives, Sodium Channel Blocker, Muscle Relaxation, Neurological Health, Clinical Development, Medicinal Compounds, Pain Relief, Anal Fissures, R&D, Licensing, Co-development Partnerships, Direct Sales, Therapeutic Applications Precision Medicines, Transcription Factors, Oncology, Drug Discovery, Small Molecule Inhibitors, Urothelial Cancer, Androgen Receptor Degrader, Transcription Factor Regulation, Integrated Discovery Platform, Emerging Pipeline, Precision Oncology, Neurology, Rare Genetic Disorders, Immunology, Inflammation
Website
algenis.com flaretx.com
Algenis logo

About Algenis

Algenis is a pioneering company in the fields of muscle relaxation and neurological health, utilizing innovative marine microalgae bioactives. The company's expertise lies in researching and developing natural sodium channel blocker molecules sourced from microalgae, aiming to lead the market in the...

Flare Therapeutics logo

About Flare Therapeutics

Flare Therapeutics, founded in 2021, is trailblazing the path to drugging transcription factors to discover precision medicines for cancer and other disease areas. This United States-based company is strategically positioned in the biopharma, biotechnology, health care, and life sciences industries....

We will tell you when either one moves

BounceWatch watches Algenis and Flare Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Algenis and Flare Therapeutics — by email.

Frequently Asked Questions

Algenis — Pioneering the future of muscle relaxation and neurological health through innovative marine microalgae bioactives.. Flare Therapeutics — Trailblazing the path to drugging transcription factors to discover precision medicines for cancer & other disease areas. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Algenis has raised undisclosed funding while Flare Therapeutics has raised $205.00M.
Algenis and Flare Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Algenis with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Algenis on 13 Sep 2024, and Flare Therapeutics on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy